Elhendy A, Geleijnse M L, Roelandt J R, van Domburg R T, TenCate F J, Cornel J H, Reijs A E, el-Said G M, Fioretti P M
Thoraxcenter, University Hospital Rotterdam, Dijkzigt, The Netherlands.
J Am Coll Cardiol. 1996 Feb;27(2):323-9. doi: 10.1016/0735-1097(95)00478-5.
This study sought to compare the clinical characteristics, hemodynamic response and severity of ischemia in patients with coronary artery disease and reversible perfusion defects on dobutamine 2-methoxy isobutyl isonitrile (MIBI) single-photon emission computed tomography (SPECT) with or without transient wall motion abnormalities.
The occurrence of reversible perfusion defects without concomitant wall motion abnormalities in patients with coronary artery disease was attributed to less severe ischemia. However, little data are available to support this observation.
Fifty-four consecutive patients with significant coronary artery disease and reversible perfusion defects on dobutamine (up to 40 micrograms/kg body weight per min) MIBI SPECT were studied (mean [+/- SD] age 59 +/- 11 years; 38 men, 16 women). All patients underwent simultaneous echocardiography. The myocardium was divided into six matched segments, and ischemic perfusion score was quantitatively derived in myocardial segments with reversible defects.
New or worsening wall motion abnormalities occurred in 40 patients (74%) (group A) and were absent in 14 (26%) (group B). There was no significant difference between the two groups with respect to age, previous myocardial infarction, number of abnormal coronary arteries (1.8 +/- 0.8 vs. 1.6 +/- 0.9), number of reversible perfusion defects (1.6 +/- 0.9 vs. 1.8 +/- 0.7) or ischemic perfusion score (412 +/- 750 vs. 526 +/- 553). Patients in group A had a higher prevalence of male gender (80% vs. 43%, p < 0.01), higher peak systolic blood pressure (147 +/- 30 vs. 127 +/- 31 mm Hg, p < 0.05), higher peak rate-pressure product (19,632 +/- 4,081 vs. 16,939 +/- 4,344, p < 0.01) and a higher prevalence of angina (53% vs. 14%) and ST segment depression (55% vs. 14%) than group B (p < 0.05 for both).
In patients with coronary artery disease and ischemia on dobutamine MIBI SPECT, the absence of transient wall motion abnormalities is associated with a similar extent and severity of reversible perfusion defects, a lower stress rate-pressure product and a higher prevalence of female gender than patients with transient wall motion abnormalities. Mechanically silent ischemia should not be regarded as a marker of less severe ischemia on myocardial perfusion scintigraphy.
本研究旨在比较冠状动脉疾病患者在多巴酚丁胺负荷2-甲氧基异丁基异腈(MIBI)单光子发射计算机断层扫描(SPECT)检查时有或无短暂室壁运动异常情况下的临床特征、血流动力学反应及缺血严重程度。
冠状动脉疾病患者出现可逆性灌注缺损但无伴随室壁运动异常被认为是缺血程度较轻。然而,几乎没有数据支持这一观点。
对54例连续的冠状动脉疾病患者进行研究,这些患者在多巴酚丁胺(最大剂量40微克/千克体重每分钟)负荷MIBI SPECT检查时有可逆性灌注缺损(平均年龄[±标准差]59±11岁;男性38例,女性16例)。所有患者同时接受超声心动图检查。心肌被分为六个匹配节段,对有可逆性缺损的心肌节段进行缺血灌注评分定量分析。
40例患者(74%)(A组)出现新的或加重的室壁运动异常,14例(26%)(B组)未出现。两组在年龄、既往心肌梗死、异常冠状动脉数量(1.8±0.8对1.6±0.9)、可逆性灌注缺损数量(1.6±0.9对1.8±0.7)或缺血灌注评分(412±750对526±553)方面无显著差异。A组男性患病率更高(80%对43%,p<0.01),收缩压峰值更高(147±30对127±31毫米汞柱,p<0.05),心率-血压乘积峰值更高(19,632±4,081对16,939±4,344,p<0.01),心绞痛患病率(53%对14%)和ST段压低患病率(55%对14%)均高于B组(两者p<0.05)。
在冠状动脉疾病且多巴酚丁胺负荷MIBI SPECT检查有缺血的患者中,与有短暂室壁运动异常的患者相比,无短暂室壁运动异常与可逆性灌注缺损的范围和严重程度相似、应激心率-血压乘积较低及女性患病率较高相关。心肌灌注显像时,机械性无反应性缺血不应被视为缺血程度较轻的标志。